Alnylam Pharmaceuticals gross margin for the quarter ending December 31, 2024 was 85.59%.
Alnylam Pharmaceuticals average gross margin for 2023 was 82.9%, a 0.9% increase from 2022.
Alnylam Pharmaceuticals average gross margin for 2022 was 83.65%, a 0.46% decline from 2021.
Alnylam Pharmaceuticals average gross margin for 2021 was 83.27%, a 2.25% increase from 2020.
Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.